Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Fairmount Funds Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$122M
Portfolio companies 13
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.13
Exits 8
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Life Science
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Fairmount Funds Management:
Typical Co-investors
Fairmount Funds Management is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Fairmount Funds Management:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AE Jarrah Capital Group -
Commenda Capital Atlanta, Georgia, United States
Grindrod Durban, KwaZulu-Natal, South Africa
Grupo Prisma Chile, Santiago Metropolitan Region, Vitacura
Macif Innovation -
Race Capital California, Hayward, United States
Sibessor 2 -
STV Group Douglassville, Pennsylvania, United States
Yingke Beite Investment Management Enterprise China, Guangdong, Shenzhen
Yorkshire Cancer Research Harrogate, North Yorkshire, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Apogee Therapeutics

Biotechnology
Life Science
Medical
Therapeutics
$149M07 Dec 2022 San Francisco, California, United States

Dianthus Therapeutics

Biopharma
Biotechnology
Health Care
$100M19 Apr 2022 Waltham, Massachusetts, United States

Apogee Therapeutics

Biotechnology
Life Science
Medical
Therapeutics
$20M01 Jan 2022 San Francisco, California, United States

Nuvalent

Biotechnology
Life Science
Therapeutics
$135M11 May 2021 Cambridge, Massachusetts, United States

Zenas BioPharma

Biopharma
Health Care
Pharmaceutical
23 Mar 2021 -

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Fairmount Funds Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 15
Average round size 122M
Peak activity year 2022
Lead investments 1
Follow on index 0.13
Exits 8
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Apogee Therapeutics

Biotechnology
Life Science
Medical
Therapeutics
$149M07 Dec 2022 San Francisco, California, United States

Dianthus Therapeutics

Biopharma
Biotechnology
Health Care
$100M19 Apr 2022 Waltham, Massachusetts, United States

Apogee Therapeutics

Biotechnology
Life Science
Medical
Therapeutics
$20M01 Jan 2022 San Francisco, California, United States

Nuvalent

Biotechnology
Life Science
Therapeutics
$135M11 May 2021 Cambridge, Massachusetts, United States

Zenas BioPharma

Biopharma
Health Care
Pharmaceutical
23 Mar 2021 -
Crunchbase icon

Content report

The following text will be sent to our editors: